Published in Gastroenterology on August 01, 2006
Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med (2012) 3.35
Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut (2014) 2.36
Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol (2009) 1.91
Dendritic cells in intestinal homeostasis and disease. J Clin Invest (2009) 1.83
Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease. J Immunol (2009) 1.14
Recent advances in celiac disease. World J Gastroenterol (2011) 1.03
Antigen presentation in celiac disease. Curr Opin Immunol (2009) 0.98
The adaptive immune response in celiac disease. Semin Immunopathol (2012) 0.97
Monocytes differentiated with IL-15 support Th17 and Th1 responses to wheat gliadin: implications for celiac disease. Clin Immunol (2010) 0.96
Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients. Clin Exp Immunol (2008) 0.96
Noninflammatory gluten peptide analogs as biomarkers for celiac sprue. Chem Biol (2009) 0.91
Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog (2008) 0.91
In vitro differentiation of human monocytes into dendritic cells by peptic-tryptic digest of gliadin is independent of genetic predisposition and the presence of celiac disease. J Clin Immunol (2008) 0.91
Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease. Clin Exp Immunol (2008) 0.90
Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides. J Pharmacol Exp Ther (2009) 0.88
Rapid accumulation of CD14+CD11c+ dendritic cells in gut mucosa of celiac disease after in vivo gluten challenge. PLoS One (2012) 0.87
Effect of dietary gluten on dendritic cells and innate immune subsets in BALB/c and NOD mice. PLoS One (2015) 0.84
Increased bacterial translocation in gluten-sensitive mice is independent of small intestinal paracellular permeability defect. Dig Dis Sci (2011) 0.82
Gene expression profile of peripheral blood monocytes: a step towards the molecular diagnosis of celiac disease? PLoS One (2013) 0.80
Reduced number and function of peripheral dendritic cells in coeliac disease. Clin Exp Immunol (2007) 0.79
Identification and molecular characterization of oat peptides implicated on coeliac immune response. Food Nutr Res (2016) 0.77
Increased density of tolerogenic dendritic cells in the small bowel mucosa of celiac patients. World J Gastroenterol (2015) 0.77
Interleukin-15 Constrains Mucosal T Helper 17 Cell Generation: Influence of Mononuclear Phagocytes. PLoS One (2015) 0.75
Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease. PLoS One (2017) 0.75
Structural basis for gluten intolerance in celiac sprue. Science (2002) 8.16
Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A (2003) 3.98
HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol (2003) 3.17
Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology (2002) 2.95
Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol (2003) 2.72
Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol (2008) 2.55
Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci U S A (2004) 2.33
Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol (2011) 2.31
[The grading system--balancing various interests]. Tidsskr Nor Laegeforen (2014) 1.99
Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol (2009) 1.91
Issues associated with the emergence of coeliac disease in the Asia–Pacific region: a working party report of the World Gastroenterology Organization and the Asian Pacific Association of Gastroenterology. J Gastroenterol Hepatol (2014) 1.83
Dependence of antibody-mediated presentation of antigen on FcRn. Proc Natl Acad Sci U S A (2008) 1.82
Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease. Gastroenterology (2005) 1.70
Mechanisms of disease: immunopathogenesis of celiac disease. Nat Clin Pract Gastroenterol Hepatol (2006) 1.68
HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest (2006) 1.66
Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue. J Proteome Res (2005) 1.63
Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue. Biochem J (2004) 1.63
Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. J Biol Chem (2002) 1.57
Effective shutdown in the expression of celiac disease-related wheat gliadin T-cell epitopes by RNA interference. Proc Natl Acad Sci U S A (2010) 1.57
Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation. J Immunol (2005) 1.51
High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med (2012) 1.44
The molecular basis for oat intolerance in patients with celiac disease. PLoS Med (2004) 1.40
Redox regulation of transglutaminase 2 activity. J Biol Chem (2010) 1.38
Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients. Proc Natl Acad Sci U S A (2007) 1.32
Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner. Cancer Immunol Immunother (2007) 1.24
Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease. Gastroenterology (2003) 1.24
Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion. J Immunol (2004) 1.23
Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nat Immunol (2009) 1.22
Assessing possible celiac disease by an HLA-DQ2-gliadin Tetramer Test. Am J Gastroenterol (2011) 1.19
Rapid generation of rotavirus-specific human monoclonal antibodies from small-intestinal mucosa. J Immunol (2010) 1.19
Mucosal cytokine response after short-term gluten challenge in celiac disease and non-celiac gluten sensitivity. Am J Gastroenterol (2013) 1.18
Pathomechanisms in celiac disease. Best Pract Res Clin Gastroenterol (2005) 1.18
Heterologous expression, purification, refolding, and structural-functional characterization of EP-B2, a self-activating barley cysteine endoprotease. Chem Biol (2006) 1.17
The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature (2008) 1.16
Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J Biol Chem (2004) 1.15
Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: chemical and immunological characterization. J Pharmacol Exp Ther (2004) 1.15
Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides. J Allergy Clin Immunol (2004) 1.11
Equilibrium and kinetic analysis of the unusual binding behavior of a highly immunogenic gluten peptide to HLA-DQ2. Biochemistry (2005) 1.11
Posttranslational modification of gluten shapes TCR usage in celiac disease. J Immunol (2011) 1.11
Ichthyosis prematurity syndrome: clinical evaluation of 17 families with a rare disorder of lipid metabolism. J Am Acad Dermatol (2011) 1.06
Human dendritic cell expression of HLA-DO is subset specific and regulated by maturation. J Immunol (2006) 1.06
The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes. PLoS One (2010) 1.05
Gluten T cell epitope targeting by TG3 and TG6; implications for dermatitis herpetiformis and gluten ataxia. Amino Acids (2010) 1.04
Activation of extracellular transglutaminase 2 by thioredoxin. J Biol Chem (2011) 1.03
A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations. J Invest Dermatol (2002) 1.03
INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn's disease? A randomized controlled trial. Inflamm Bowel Dis (2011) 1.00
Long-lived plasma cells from human small intestine biopsies secrete immunoglobulins for many weeks in vitro. J Immunol (2011) 1.00
Antigen presentation in celiac disease. Curr Opin Immunol (2009) 0.98
Specific modification of peptide-bound citrulline residues. Anal Biochem (2006) 0.98
Ichthyosis prematurity syndrome caused by a novel fatty acid transport protein 4 gene mutation in a German infant. Arch Dermatol (2011) 0.97
The adaptive immune response in celiac disease. Semin Immunopathol (2012) 0.97
Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn's disease patients. PLoS One (2009) 0.97
Inhibition of HLA-DQ2-mediated antigen presentation by analogues of a high affinity 33-residue peptide from alpha2-gliadin. J Am Chem Soc (2006) 0.97
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions. Biochim Biophys Acta (2008) 0.96
Tolerance to ingested deamidated gliadin in mice is maintained by splenic, type 1 regulatory T cells. Gastroenterology (2011) 0.96
Epithelial-microbial crosstalk in polymeric Ig receptor deficient mice. Eur J Immunol (2012) 0.96
Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study. Ann Rheum Dis (2012) 0.96
Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature. Rheumatology (Oxford) (2013) 0.94
A mouse C kappa-specific T cell clone indicates that DC-SIGN is an efficient target for antibody-mediated delivery of T cell epitopes for MHC class II presentation. Int Immunol (2002) 0.93
A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease. J Proteome Res (2009) 0.93
Biased usage and preferred pairing of α- and β-chains of TCRs specific for an immunodominant gluten epitope in coeliac disease. Int Immunol (2013) 0.93
Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients. Inflamm Bowel Dis (2011) 0.92
T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease. Gastroenterology (2011) 0.92
Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells. J Immunol (2013) 0.91
Meta and pooled analysis of European coeliac disease data. Eur J Hum Genet (2003) 0.91
Noninflammatory gluten peptide analogs as biomarkers for celiac sprue. Chem Biol (2009) 0.91
DNA transfection of mononuclear cells in muscle tissue. J Gene Med (2003) 0.91
Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires. Immunogenetics (2014) 0.91
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection. Blood (2005) 0.90
Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles. Immunogenetics (2003) 0.90